Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ibtissam Gad"'
Autor:
Alyssa Lange, Lenche Kostadinova, Sofi Damjanovska, Ibtissam Gad, Sameena Syed, Husna Siddiqui, Patrick Yousif, Corinne M. Kowal, Carey Shive, Christopher Burant, Nora Singer, Taissa Bej, Sadeer Al-Kindi, Brigid Wilson, Maya Mattar, David A. Zidar, Donald D. Anthony
Publikováno v:
The Journal of Rheumatology. 50:166-174
ObjectiveMorbidity and mortality in rheumatoid arthritis (RA) is partly mitigated by maintaining immune and hematologic homeostasis. Identification of those at risk is challenging. Red cell distribution width (RDW) and absolute lymphocyte count (ALC)
Autor:
Layth Dahbour, Imran Ali, Ibtissam Gad, Sara Q. Perkins, Sally Itawi, Graham Mitro, Zachary Rotter, Courtney Rusch, Sarah Williams, Xiao-Wei Cherie Tan
Publikováno v:
Journal of Religion and Health. 61:1120-1138
According to many studies, addressing the religious and spiritual (R/S) needs of patient's increase patient satisfaction. One area of interest is how patient self-perceived level of religiosity and spirituality (R/S) influences hospital needs. In thi
Autor:
Samkeliso Dlamini, Sara R. Fedorka, Maisha S. Rashid, William R. Taylor, Veronika Kholodovych, Radhika Koranne, Mark W. Jackson, Tim Rogers, Ayad A. Al-Hamashi, Ibtissam Gad, Damian J. Junk, L. M. Viranga Tillekeratne, Nishanth Kuganesan, Yusuf Barudi, Hanan D. Alqahtani, Ronit Shah
Publikováno v:
Scientific Reports
Scientific Reports, Vol 9, Iss 1, Pp 1-14 (2019)
Scientific Reports, Vol 9, Iss 1, Pp 1-14 (2019)
Effective management of advanced cancer requires systemic treatment including small molecules that target unique features of aggressive tumor cells. At the same time, tumors are heterogeneous and current evidence suggests that a subpopulation of tumo
Autor:
Sara R. Fedorka, Kevin So, Ronit Shah, Veronika Kholodovych, Hanan D. Alqahtani, Ibtissam Gad, Ayad A. Al-Hamashi, L. M. Viranga Tillekeratne, William R. Taylor
Publikováno v:
Organicbiomolecular chemistry. 16(9)
In the course of generating a library of open-chain epothilones, we discovered a new class of small molecule anticancer agents that has no effect on tubulin but instead kills selected cancer cell lines by harnessing reactive oxygen species in an iron